Home > Press > Wageningen University Orders FEI Magellan Scanning Electron Microscope for High-Resolution Surface Imaging of Biological Materials
Abstract:
Netherlands-based lab will use the Magellan for sub-nanometer imaging in plant sciences,
agro-technology, nutrition and food sciences.
FEI Company (Nasdaq: FEIC), a leading provider of atomic-scale imaging and analysis systems, today announced the sale of a Magellan™ extreme high-resolution scanning electron microscope (XHR SEM) to Wageningen University, The Netherlands. The Magellan is the only family of SEMs that provides high-throughput, sub-nanometer resolution at low accelerating voltages, while retaining the flexibility and ease-of-use that are characteristic of SEM technology.
According to Adriaan van Aelst, manager, Wageningen Electron Microscopy Centre, Wageningen University, "The Magellan XHR SEM will serve as an essential imaging and analysis tool in our microscopy lab. It will enable us to extend our SEM analysis to sub-nanometer, high-resolution SEM imaging at low voltages, and at ambient and low temperatures. The Magellan's combination of low-voltage imaging with high-resolution power is essential to analyzing very small and fragile surface structures."
High-resolution SEM has traditionally required the use of higher accelerating voltages in order to diminish the beam broadening effects of chromatic aberration. However, higher beam energies can damage the sample and degrade both the resolution and surface specificity of the signal as the beam penetrates more deeply beneath the surface, particularly in light-element biological materials. The Magellan provides sub-nanometer resolution over the full range of beam energies, from less than one kiloVolt (kV) to 30kV, allowing high-resolution, ultra-structural imaging of sensitive biological samples. Equally important, it does so without imposing additional constraints on the sample or increasing operational complexity.
"With the Magellan, FEI has designed a SEM that is in a class by itself," said Matthew Harris, FEI's vice president and general manager for the Life Sciences Division. "It complements the other leading technologies that FEI offers for ultra-structural imaging, including the Titan Krios™ in the high-end TEM segment, and the Helios NanoLab™ in the DualBeam™ segment. Now, with Magellan, we have made high-throughput SEM imaging of biological samples a practical reality for life sciences research."
Harris adds, "We are pleased that the Magellan XHR SEM has been recognized by an independent judging panel and editors of R&D Magazine with the ‘2009 R&D 100 Award'. This award recognizes the 100 most technologically-significant products introduced for research in the past year."
The Magellan XHR SEM will be located in the Wageningen Electron Microscopy Centre in the new RADIX Building at the University. The system was shipped to Wageningen University during the first week of July 2009.
####
About FEI Company
FEI (Nasdaq: FEIC) is a leading diversified scientific instruments company. It is a premier provider of electron and ion-beam microscopes and tools for nanoscale applications across many industries: industrial and academic materials research, life sciences, semiconductors, data storage, natural resources and more. With a 60-year history of technological innovation and leadership, FEI has set the performance standard in transmission electron microscopes (TEM), scanning electron microscopes (SEM) and DualBeams™, which combine a SEM with a focused ion beam (FIB). FEI’s imaging systems provide 3D characterization, analysis and modification/prototyping with resolutions down to the sub-Ångström (one-tenth of a nanometer) level. FEI’s NanoPorts in North America, Europe and Asia provide centers of technical excellence where its world-class community of customers and specialists collaborate. FEI has approximately 1800 employees and sales and service operations in more than 50 countries around the world.
FEI Safe Harbor Statement
This news release contains forward-looking statements that include statements regarding the performance capabilities and benefits of the Magellan. Factors that could affect these forward-looking statements include but are not limited to failure of the product or technology to perform as expected and achieve anticipated results, unexpected technology problems and our ability to manufacture, ship and deliver the tools as expected. Please also refer to our Form 10-K, Forms 10-Q, Forms 8-K and other filings with the U.S. Securities and Exchange Commission for additional information on these factors and other factors that could cause actual results to differ materially from the forward-looking statements. FEI assumes no duty to update forward-looking statements.
For more information, please click here
Contacts:
Sandy Fewkes
MindWrite Communications, Inc.
ph/fx 408.224.4024
www.mind-write.com
FEI Company
Fletcher Chamberlin
(investors and analysts)
Investor Relations
+1 503 726 7710
Copyright © FEI Company
If you have a comment, please Contact us.Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.
Related News Press |
Imaging
News and information
Beyond wires: Bubble technology powers next-generation electronics:New laser-based bubble printing technique creates ultra-flexible liquid metal circuits November 8th, 2024
Nanoparticle bursts over the Amazon rainforest: Rainfall induces bursts of natural nanoparticles that can form clouds and further precipitation over the Amazon rainforest November 8th, 2024
Nanotechnology: Flexible biosensors with modular design November 8th, 2024
Exosomes: A potential biomarker and therapeutic target in diabetic cardiomyopathy November 8th, 2024
Academic/Education
Rice University launches Rice Synthetic Biology Institute to improve lives January 12th, 2024
Multi-institution, $4.6 million NSF grant to fund nanotechnology training September 9th, 2022
Announcements
Nanotechnology: Flexible biosensors with modular design November 8th, 2024
Exosomes: A potential biomarker and therapeutic target in diabetic cardiomyopathy November 8th, 2024
Turning up the signal November 8th, 2024
Nanofibrous metal oxide semiconductor for sensory face November 8th, 2024
Tools
Turning up the signal November 8th, 2024
Quantum researchers cause controlled ‘wobble’ in the nucleus of a single atom September 13th, 2024
Faster than one pixel at a time – new imaging method for neutral atomic beam microscopes developed by Swansea researchers August 16th, 2024
New-Contracts/Sales/Customers
Bruker Light-Sheet Microscopes at Major Comprehensive Cancer Center: New Advanced Imaging Center Powered by Two MuVi and LCS SPIM Microscopes March 25th, 2021
Arrowhead Pharmaceuticals Announces Closing of Agreement with Takeda November 27th, 2020
Veeco Announces Aledia Order of 300mm MOCVD Equipment for microLED Displays: Propel™ Platform First 300mm System with EFEM Designed for Advanced Display Applications October 20th, 2020
GREENWAVES TECHNOLOGIES Announces Next Generation GAP9 Hearables Platform Using GLOBALFOUNDRIES 22FDX Solution October 16th, 2020
The latest news from around the world, FREE | ||
Premium Products | ||
Only the news you want to read!
Learn More |
||
Full-service, expert consulting
Learn More |
||